APA (7th ed.) Citation

CP, P., S, W., B, C., SW, L., JSQ, T., AT, L., . . . P, L. (2024). In vivo evaluation of monoclonal antibody M4M using a humanised rat model of stroke demonstrates attenuation of reperfusion injury via blocking human TRPM4 channel. Journal of drug targeting, 32(4), 413. https://doi.org/10.1080/1061186X.2024.2313522

Chicago Style (17th ed.) Citation

CP, Poore, Wei S, Chen B, Low SW, Tan JSQ, Lee AT, Nilius B, and Liao P. "In Vivo Evaluation of Monoclonal Antibody M4M Using a Humanised Rat Model of Stroke Demonstrates Attenuation of Reperfusion Injury via Blocking Human TRPM4 Channel." Journal of Drug Targeting 32, no. 4 (2024): 413. https://doi.org/10.1080/1061186X.2024.2313522.

MLA (9th ed.) Citation

CP, Poore, et al. "In Vivo Evaluation of Monoclonal Antibody M4M Using a Humanised Rat Model of Stroke Demonstrates Attenuation of Reperfusion Injury via Blocking Human TRPM4 Channel." Journal of Drug Targeting, vol. 32, no. 4, 2024, p. 413, https://doi.org/10.1080/1061186X.2024.2313522.